| Business Summary | | Ortec
International
Inc.
is
a
development
stage
tissue
engineering
company
that
has
developed
a
proprietary
and
patented
technology,
called
Composite
Cultured
Skin
(CCS),
which
is
used
to
stimulate
the
repair
and
regeneration
of
human
skin.
Ortec's
Composite
Cultured
Skin
is
a
two-layered
tissue
engineered
dressing
that
consists
of
human
derived
skin
cells,
both
dermal
and
epidermal,
supported
within
a
porous
collagen
matrix.
The
composite
matrix
is
seeded
with
keratinocytes
for
epidermal
growth
and
fibroblasts
for
dermal
growth.
This
active
dressing
stimulates
the
repair,
replacement
and
regeneration
of
human
skin.
When
its
CCS
is
applied
to
the
wound
site,
it
produces
a
mix
of
growth
factors
that
stimulates
wound
closure. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | ORTC
is
a
development
stage
company
developing
a
proprietary
technology
which
consists
of
a
biologically
active
dressing
to
stimulate
the
repair
and
regeneration
of
human
skin.
For
the
three
months
ended
3/31/01,
revenues
decreased
31%
to
$114
thousand.
Net
loss
increased
32%
to
$3.5
million.
Revenues
reflect
decreased
interest
income.
Higher
loss
reflects
increased
R&D
and
personnel
expenses
due
to
costs
associated
with
increased
clinical
trial
activity. Recent Earnings Announcement For
the
3
months
ended
06/30/2001,
revenues
were
5;
after
tax
earnings
were
-3,753. (Preliminary; reported in thousands of dollars.) | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| Steven Katz, Ph.D., 56 Chairman,
CEO | $313K | Costa Papastephanou, Ph.D., 55 Pres | -- | Ron Lipstein, 45 Vice
Chairman, CFO, Sec., Treasurer | 267K | William Schaeffer, 53 COO | 167K | Mark Eisenberg, M.D., 63 Sr.
VP, R&D | -- | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|